IMIDAZOLINE RECEPTORS - A NEW CONCEPT IN CENTRAL REGULATION OF THE ARTERIAL BLOOD-PRESSURE

被引:50
作者
BOUSQUET, P
FELDMAN, J
TIBIRICA, E
BRICCA, G
GRENEY, H
DONTENWILL, M
STUTZMANN, J
BELCOURT, A
机构
[1] Institut de Pharmacologie, CNRS URA 589, Strasbourg, 67000
关键词
Central nervous system; Hypotension; Imidazoline preferring receptors; Locus coeru- leus; Nucleus reticularis lateralis; Rilmenidine;
D O I
10.1093/ajh/5.4.47S
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Clonidine-like antihypertensive substances bind to nonadrenergic imidazoline specific sites within the nucleus reticularis lateralis (NRL), their medullary privileged site of action. Rilmenidine, a new central antihypertensive agent, was tested in the anesthetized rabbit. For the same hypotensive effect, cumulative doses given intracisternally proved 50 times more active than of those given systemically. Idazoxan, an alpha-2-adrenergic antagonist structurally related to the imidazolines, given centrally as pretreatment proved more potent in preventing the hypotensive effects than the same molar dose of yohimbine. When injected within the NRL area of the anesthetized rabbit, rilmenidine, like clonidine, always exhibited a hypotensive effect. The influence of clonidine and rilmenidine upon the NRL noradrenergic neurons involved in the blood pressure regulation, and upon those of the locus coeruleus (LC) involved in the sedative effect was studied by differential voltammetry. It was observed that rilmenidine was two times more selective than clonidine in inhibiting the NRL, as opposed to LC, neuronal activity. In addition, binding experiments of tritiated clonidine to human cortical and NRL membrane preparations showed that rilmenidine, as compared to clonidine, has a two to three times higher selectivity for the imidazoline receptors. In conclusion, we are now able to discriminate between the mechanism of the hypotensive effect of imidazoline-like drugs and that of their sedative action. Rilmenidine is the first example of an hypotensive drug more selective for imidazoline preferring receptors than for classical alpha-2-adrenoceptors.
引用
收藏
页码:S47 / S50
页数:4
相关论文
共 21 条
[1]  
Bousquet P., Feldman J., Schwartz J., Central cardiovascular effects of a-adrenergic drugs: Differences between catecholamines and imidazolines, J Pharmacol Exp Ther, 230, pp. 232-236, (1984)
[2]  
Bricca G., Dontenwill M., Molines A., Et al., Evidences for the existence of a homogenous population of imidazoline receptors in the human brainstem, Eur J Pharmacol, 150, pp. 401-402, (1988)
[3]  
Bricca G., Dontenwill M., Molines A., Et al., The imidazoline preferring receptor: Binding studies in bovine rat and human brainstem, Eur J Pharmacol, 162, pp. 1-9, (1989)
[4]  
Emsberger P., Meeley M.P., Reis D.J., An endogenous substance with clonidine like properties: Selective binding to imidazole sites in the ventrolateral medulla, Eur J Pharmacol, 134, pp. 1-13, (1988)
[5]  
Hamilton C.A., Reid J.L., Yakubu M.A., (3H)-Yohimbine and (3H)-idazoxan bind to different sites on rabbit forebrain and kidney membranes, Eur J Pharmacol, 146, (1988)
[6]  
Langin D., Lafontan M: (3H)-Idazoxan binding at non a2-adrenoceptors in rabbit adipocyte membranes, Eur J Pharmacol, 159, pp. 199-203, (1989)
[7]  
Coupry I., Podevin R.A., Dausse J.P., Et al., Evidence for imidazoline binding site in basolateral membranes from rabbit kidney, Biochem Biophys Res Commun, 147, pp. 1055-1060, (1987)
[8]  
Zonnenschein R., Diamant S., Atlas D., Imidazoline receptors in rat liver cells: A novel receptor of a subtype of a:2-adrenergic receptors, Eur J Pharmacol, 190, (1991)
[9]  
Emsberger P., Meeley J.P., Mann J.J., Clonidinebinds to imidazole binding sites as well as a2-adrenoceptors in the ventrolateral medulla, Eur J Pharmacol, 134, pp. 1-13, (1987)
[10]  
Emsberger P., Giuliano R., Willette R.N., Et al., Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla, J Pharm Exp Ther, 253, pp. 408-418, (1990)